After $10B in market value lost, China's WuXi Biologics removed from US unverified list
WuXi Biologics has cause to celebrate as it finds itself removed from the US Department of Commerce’s unverified list.
The China-based contract research and manufacturing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
